Co-Occurring Disorders Editor · Last reviewed January 2025
Understanding the mental health dimensions of opioid use disorder — how it affects brain chemistry, which mental health conditions most commonly co-occur, and how integrated treatment addresses both — is essential for anyone navigating recovery or supporting someone who is.
How opioid Affects Mental Health
Opioids act on mu-opioid receptors throughout the brain and body, producing analgesia, euphoria, and reduced anxiety acutely. Chronic opioid use causes profound changes in the endogenous opioid system and HPA axis, disrupting the brain's natural stress response. The dysphoria, anxiety, and depression of withdrawal and post-acute withdrawal syndrome (PAWS) can persist for months after cessation, creating powerful neurobiological drivers of relapse in individuals not adequately supported through this period.
Most Common Co-Occurring Mental Health Conditions
Opioid use disorder carries extremely high rates of co-occurring mental health conditions. Research consistently finds that 50–70% of individuals with OUD have at least one co-occurring psychiatric disorder. Depression and PTSD are particularly prevalent — studies of individuals in opioid treatment programs find PTSD rates of 30–40% and major depression in similar ranges. The most frequently co-occurring conditions with opioid use disorder include major depression, PTSD, anxiety disorders, and chronic pain-related mood disorders. These relationships are bidirectional: mental health conditions can drive opioid use as self-medication, while opioid use can cause, worsen, or maintain mental health symptoms through direct neurobiological effects and lifestyle disruption.
Diagnostic Challenges
opioid produces psychiatric symptoms during intoxication and withdrawal that can mimic primary mental health conditions. Careful assessment — ideally after a period of abstinence or stable use — is essential for accurate diagnosis. However, severe psychiatric symptoms that persist well beyond acute intoxication or withdrawal are more likely to reflect a primary co-occurring condition requiring treatment in its own right.
Integrated Treatment
Medication-assisted treatment with buprenorphine, methadone, or extended-release naltrexone is the evidence-based standard for opioid use disorder and should be provided alongside mental health treatment in co-occurring presentations. MAT stabilizes neurobiological function and reduces cravings, making engagement with psychotherapy far more feasible. SSRIs/SNRIs are appropriate for co-occurring depression and anxiety. Trauma-informed care and specific PTSD treatment — Seeking Safety, CPT, or Prolonged Exposure — should be integrated for the substantial proportion of individuals with PTSD. Chronic pain management, which commonly co-occurs with OUD, requires a multimodal non-opioid approach in individuals in recovery.
Getting Help
SAMHSA's National Helpline (1-800-662-4357) provides free, confidential treatment referrals 24/7. The treatment locator at findtreatment.gov allows searching for dual diagnosis programs by location.
Related: PTSD & Addiction · Medication-Assisted Treatment · Depression & Addiction